GHK-Cu and peptides for glass skin: what TikTok won't tell you

What's this video probably claiming?

Based on the hashtags and creator context, @everythingskintalk is almost certainly talking about GHK-Cu (copper tripeptide-1) as a topical or systemic skincare ingredient that delivers "glass skin" results, the kind of semi-translucent, poreless look that dominates Korean beauty content. Given the peptide category tag, there's a good chance the video also touches on systemic peptides, possibly CJC-1295, ipamorelin, or BPC-157, framed as anti-aging compounds that work from the inside out. The "I can't believe this" caption is a well-worn hook for dramatic before-and-after framing. Expect claims about collagen stimulation, skin barrier repair, and possibly wound healing being extrapolated to cosmetic rejuvenation. Whether topical GHK-Cu or injectables are the focus matters enormously, because the evidence base for each is radically different, and conflating them is exactly the kind of thing that makes this category scientifically messy.

What does the science actually show?

GHK-Cu has a reasonably interesting research record for a cosmetic peptide. Pickart and Margolina (2018, Cosmetics) reviewed decades of in vitro and animal data showing GHK-Cu can upregulate collagen synthesis, activate antioxidant genes, and modulate TGF-beta pathways. A small double-blind trial by Leyden et al. (2018, Journal of Cosmetic Dermatology) found that a 1% GHK-Cu cream applied twice daily for 12 weeks produced measurable improvements in skin laxity and fine lines versus vehicle control. Real, but modest. The effect sizes were not transformative. On the systemic peptide side, CJC-1295 combined with ipamorelin does produce statistically significant growth hormone pulse amplification, as shown by Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism), but connecting that hormonal shift to visible skin changes in healthy adults is a much longer and less established chain of causation. MK-677 studies show similar GH elevation but carry documented risks including insulin resistance and edema.

Where does the social media noise diverge from clinical reality?

The gap is significant. TikTok peptide content routinely treats in vitro cell culture data as proof of human outcomes. A study showing GHK-Cu stimulates fibroblasts in a dish is not evidence that rubbing a serum on your face gives you new collagen at clinical scale. The "glass skin" framing is aesthetic marketing language, not a measurable clinical endpoint. No randomized controlled trial has used glass skin as an outcome measure, because it isn't one. More concerning is the conflation of topical GHK-Cu, which has some human trial support, with injectable peptides like BPC-157 or TB-500, which have zero FDA approval for cosmetic use and whose human safety data is thin. Semax and selank, also in this category, are not approved in the US and exist in a regulatory gray zone. Creators rarely explain that systemic peptides require a prescribing clinician, laboratory baseline work, and ongoing monitoring. Presenting them alongside a K-beauty skincare routine erases that distinction entirely.

What should you actually know?

Topical GHK-Cu at concentrations between 0.5% and 2% has the most defensible evidence in this space, and even that evidence is limited to small, short-duration trials. If you're interested in peptide-based skincare, look for formulations that list copper tripeptide-1 or GHK-Cu with a concentration disclosed, and pair expectations with the actual trial data, not before-and-after content. For systemic peptides marketed as anti-aging tools, the risk-benefit picture is genuinely unclear. Growth hormone secretagogues like ipamorelin or MK-677 alter real hormonal axes. That is not a cosmetic decision you make based on a TikTok video. The FDA has not approved any of the injectable peptides in this category for anti-aging or aesthetic indications. If a creator is implying otherwise, that's a compliance problem, not just a science communication gap. Anyone interested in peptide therapy for skin or systemic anti-aging should be working with a licensed clinician who can review bloodwork and monitor for side effects.